A computational analysis of COVID-19 tests suggests that, in order to minimize the number of infections in a population, the amount of testing matters more than the sensitivity of the tests that are used.
The US FDA revoked the emergency use authorization of the DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test from Chembio Diagnostic System Inc, due to performance concerns with the accuracy of the test.Read More
The US FDA issued an emergency use authorization for the Illumina COVIDSeq Test, the first COVID-19 diagnostic test utilizing next generation sequence technology.Read More
The CDC is seeking emergency use authorization for a new diagnostic test that can simultaneously detect the SARS-CoV-2 coronavirus and the influenza virus.Read More
The US FDA issued an emergency use authorization for the Everlywell COVID-19 Test Home Collection Kit, an at-home sample collection kit that allows screened patients to collect and send a nasal swab sample for testing.Read More
Quest Diagnostics has launched a consumer-based COVID-19 antibody test called QuestDirect, which can be ordered online without the need for a doctor’s visit.Read More
The US FDA has approved the use of spun synthetic swabs similar to Q-tips for use in testing for COVID-19. The swabs can be used for self-administered home testing for coronavirus, the FDA says.Read More